WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > Preferred Homecare / Lifecare Solutions
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Webinar
Future of Healthcare, Medical Devices
Novateur Ventures | December 13, 2022
Novateur Ventures, a leading global life sciences advisory firm and Biotechnology Innovation Organization the world's largest advocacy association for biosciences, research and academic institutions, launched an industry networking information app, Event Guide to JPM 2023, which provides listings for an anticipated >200 satellite networking events taking place during the 41st Annual J.P. Morgan Health Care Conference on January 9-12, 2023, in San Francisco, CA. The Event Guid...
Health Technology
HealthLynked | September 28, 2021
HealthLynkeda global healthcare network focused on care management of its members and a provider of healthcare technologies that connect doctors, patients, and medical data, announced today the launch of its new patient check in system, QwikCheck V2.0. The new version offers a streamlined process for practices to institute remote patient check-in without the need for any additional hardware. The new check-in system uses dynamic linking, which allows a single QR code tied to a practice t...
Digital Healthcare, Healthcare Analytics
Businesswire | April 21, 2023
SYNERGEN Health, an industry-leading provider of technology-enabled revenue cycle services and solutions for healthcare organizations, and PreciseMDX, a technology provider offering best-in-class lab management software that empowers and connects labs, care providers, and patients, today announce their strategic partnership to provide laboratories and diagnostics with a seamless, end-to-end revenue cycle solution to bolster operational efficiencies, scalability, and growth. The collaborati...
FDA | April 24, 2020
The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems. The decades-old drug has been called a “game changer” by Trump in the fight against the novel coronavirus and anecdotal reports that it may provide some benefit have spurred sales of the drug. Within hours of Trump&rsquo...
Article
Health Technology, Medical Devices
Video
Healthtech Security, Digital Healthcare
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE